NM_033159.4:c.802G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_033159.4(HYAL1):c.802G>A(p.Glu268Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033159.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HYAL1 | NM_033159.4 | c.802G>A | p.Glu268Lys | missense_variant | Exon 2 of 4 | ENST00000395144.7 | NP_149349.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251402Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135902
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000399 AC XY: 29AN XY: 727240
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74470
ClinVar
Submissions by phenotype
Deficiency of hyaluronoglucosaminidase Pathogenic:1Uncertain:2
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 268 of the HYAL1 protein (p.Glu268Lys). This variant is present in population databases (rs104893743, gnomAD 0.02%). This missense change has been observed in individual(s) with mucopolysaccharidosis type IX (PMID: 10339581). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3530). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
The HYAL1 c.802G>A (p.Glu268Lys) variant is a missense variant that has been reported in one study in which it is found in a compound heterozygous state with a stop-gained variant in one individual with mucopolysaccharidosis IX (Triggs-Raine et al., 1999; Natowicz et al., 1996). The patient's unaffected father and paternal grandmother both carried the variant in a heterozygous state. The variant was not found in 100 control alleles and is reported at a frequency of 0.000256 in the European (non-Finnish) population of the Exome Aggregation Consortium. The patient had deficient serum hyaluronidase activity and 38- to 90-fold elevated concentration of serum hyaluronic acid (Natowicz et al., 1996). Triggs-Raine et al. (1999) predict the variant to disrupt HYAL1 activity because of the difference in charges between the glutamine and lysine residues. The Glu268 residue is highly conserved and is likely critical for the function of an active site in the HYAL1 protein. In silico analysis of native and mutant HYAL demonstrated differences in folding pattern, secondary structure elements, dihedral angles, and binding strength (Paul & Rajasekaran 2017). The evidence for this variant is limited. The p.Glu268Lys variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for mucopolysaccharidosis, type IX. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at